1,2-dimethylhydrazine multiple interactions ISO RGD:731351 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP5F1D mRNA CTD PMID:22206623 14-Deoxy-11,12-didehydroandrographolide decreases expression ISO RGD:1353040 6480464 14-deoxy-11, 12-didehydroandrographolide results in decreased expression of ATP5F1D mRNA CTD PMID:22101062 17alpha-ethynylestradiol increases expression ISO RGD:731351 6480464 Ethinyl Estradiol results in increased expression of ATP5F1D mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:731351 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5F1D mRNA CTD PMID:17942748 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ATP5F1D mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP5F1D mRNA CTD PMID:27913140 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP5F1D mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731351 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5F1D mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731351 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP5F1D mRNA CTD PMID:20399798 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731351 6480464 Tetrachlorodibenzodioxin affects the expression of ATP5F1D mRNA CTD PMID:21570461 , PMID:24680724 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ATP5F1D mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine increases expression ISO RGD:731351 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ATP5F1D mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1353040 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ATP5F1D mRNA CTD PMID:28628672 5-fluorouracil multiple interactions ISO RGD:1353040 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of ATP5F1D mRNA] CTD PMID:15016801 5-fluorouracil affects expression ISO RGD:1353040 6480464 Fluorouracil affects the expression of ATP5F1D mRNA CTD PMID:34151400 acrolein multiple interactions ISO RGD:1353040 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ATP5F1D mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ATP5F1D mRNA CTD PMID:32699268 aldehydo-D-glucose multiple interactions EXP 6480464 15-Hydroxy-11 alpha more ... CTD PMID:25305180 alpha-pinene multiple interactions ISO RGD:1353040 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ATP5F1D mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ATP5F1D mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ATP5F1D mRNA CTD PMID:16483693 amphetamine multiple interactions ISO RGD:731351 6480464 Amphetamine inhibits the reaction [MDK gene mutant form results in decreased expression of ATP5F1D protein], PTN gene mutant form inhibits the reaction [Amphetamine results in decreased expression of ATP5F1D protein] CTD PMID:23459167 amphetamine decreases expression ISO RGD:731351 6480464 Amphetamine results in decreased expression of ATP5F1D protein CTD PMID:23459167 aristolochic acid A increases expression ISO RGD:1353040 6480464 aristolochic acid I results in increased expression of ATP5F1D protein CTD PMID:33212167 benzo[a]pyrene increases methylation ISO RGD:1353040 6480464 Benzo(a)pyrene results in increased methylation of ATP5F1D 3' UTR CTD PMID:27901495 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of ATP5F1D mRNA CTD PMID:16648578 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ATP5F1D mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:731351 6480464 bisphenol A results in increased expression of ATP5F1D mRNA CTD PMID:32156529 bisphenol A decreases expression ISO RGD:731351 6480464 bisphenol A results in decreased expression of ATP5F1D mRNA CTD PMID:35598803 bisphenol A multiple interactions ISO RGD:1353040 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ATP5F1D mRNA CTD PMID:28628672 bisphenol A affects expression ISO RGD:1353040 6480464 bisphenol A affects the expression of ATP5F1D mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP5F1D mRNA, bisphenol A results in decreased expression of ATP5F1D protein CTD PMID:20219716 more ... cadmium atom increases expression ISO RGD:731351 6480464 Cadmium results in increased expression of ATP5F1D mRNA CTD PMID:26187450 carmustine decreases expression ISO RGD:1353040 6480464 Carmustine results in decreased expression of ATP5F1D mRNA CTD PMID:15980968 chlorpyrifos increases expression ISO RGD:731351 6480464 Chlorpyrifos results in increased expression of ATP5F1D mRNA CTD PMID:37019170 choline multiple interactions ISO RGD:731351 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATP5F1D gene CTD PMID:20938992 cisplatin decreases expression ISO RGD:1353040 6480464 Cisplatin results in decreased expression of ATP5F1D mRNA CTD PMID:27594783 clofibrate multiple interactions ISO RGD:731351 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ATP5F1D mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATP5F1D mRNA] CTD PMID:17585979 cyclosporin A decreases expression ISO RGD:1353040 6480464 Cyclosporine results in decreased expression of ATP5F1D mRNA CTD PMID:20106945 , PMID:25562108 D-glucose multiple interactions EXP 6480464 15-Hydroxy-11 alpha more ... CTD PMID:25305180 dexamethasone multiple interactions ISO RGD:1353040 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ATP5F1D mRNA CTD PMID:28628672 dibutyl phthalate decreases expression ISO RGD:731351 6480464 Dibutyl Phthalate results in decreased expression of ATP5F1D mRNA CTD PMID:21266533 dioxygen multiple interactions EXP 6480464 15-Hydroxy-11 alpha more ... CTD PMID:25305180 dioxygen decreases expression ISO RGD:731351 6480464 Oxygen deficiency results in decreased expression of ATP5F1D protein CTD PMID:25937538 doxorubicin decreases expression ISO RGD:1353040 6480464 Doxorubicin results in decreased expression of ATP5F1D mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:731351 6480464 Doxorubicin results in decreased expression of ATP5F1D protein CTD PMID:21251210 doxorubicin affects expression ISO RGD:1353040 6480464 Doxorubicin affects the expression of ATP5F1D protein CTD PMID:29385562 epoxiconazole increases expression ISO RGD:731351 6480464 epoxiconazole results in increased expression of ATP5F1D mRNA CTD PMID:35436446 ethyl methanesulfonate decreases expression ISO RGD:1353040 6480464 Ethyl Methanesulfonate results in decreased expression of ATP5F1D mRNA CTD PMID:23649840 fenthion increases expression ISO RGD:731351 6480464 Fenthion results in increased expression of ATP5F1D mRNA CTD PMID:34813904 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ATP5F1D mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:731351 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 gamma-hexachlorocyclohexane decreases expression EXP 6480464 Hexachlorocyclohexane results in decreased expression of ATP5F1D mRNA CTD PMID:17785943 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ATP5F1D mRNA CTD PMID:15350274 glucose multiple interactions EXP 6480464 15-Hydroxy-11 alpha more ... CTD PMID:25305180 glyphosate decreases expression EXP 6480464 glyphosate results in decreased expression of ATP5F1D mRNA CTD PMID:26302742 indometacin multiple interactions ISO RGD:1353040 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ATP5F1D mRNA CTD PMID:28628672 isoprenaline multiple interactions EXP 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5F1D mRNA CTD PMID:30303030 ivermectin decreases expression ISO RGD:1353040 6480464 Ivermectin results in decreased expression of ATP5F1D protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:731351 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATP5F1D gene CTD PMID:20938992 lipopolysaccharide multiple interactions ISO RGD:1353040 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5F1D mRNA CTD PMID:31059760 lithium atom increases expression EXP 6480464 Lithium results in increased expression of ATP5F1D protein CTD PMID:18296634 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of ATP5F1D protein CTD PMID:18296634 methidathion increases expression ISO RGD:731351 6480464 methidathion results in increased expression of ATP5F1D mRNA CTD PMID:34813904 methotrexate affects response to substance ISO RGD:1353040 6480464 ATP5F1D protein affects the susceptibility to Methotrexate CTD PMID:16217747 methyl methanesulfonate decreases expression ISO RGD:1353040 6480464 Methyl Methanesulfonate results in decreased expression of ATP5F1D mRNA CTD PMID:23649840 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of ATP5F1D mRNA CTD PMID:24136188 niclosamide increases expression ISO RGD:1353040 6480464 Niclosamide results in increased expression of ATP5F1D mRNA CTD PMID:22576131 notoginsenoside R1 multiple interactions EXP 6480464 15-Hydroxy-11 alpha more ... CTD PMID:25305180 ochratoxin A increases expression ISO RGD:1353040 6480464 ochratoxin A results in increased expression of ATP5F1D mRNA CTD PMID:17316727 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of ATP5F1D protein CTD PMID:31369848 okadaic acid multiple interactions ISO RGD:1353040 6480464 [Okadaic Acid co-treated with gambierol] results in increased expression of ATP5F1D protein CTD PMID:19397276 okadaic acid decreases expression ISO RGD:1353040 6480464 Okadaic Acid results in decreased expression of ATP5F1D protein CTD PMID:19397276 ozone multiple interactions ISO RGD:1353040 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ATP5F1D mRNA more ... CTD PMID:32699268 paracetamol affects response to substance ISO RGD:1353040 6480464 ATP5F1D gene polymorphism affects the susceptibility to Acetaminophen CTD PMID:26104854 paracetamol increases expression ISO RGD:731351 6480464 Acetaminophen results in increased expression of ATP5F1D protein CTD PMID:21329376 paracetamol multiple interactions ISO RGD:731351 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ATP5F1D mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATP5F1D mRNA] CTD PMID:17585979 paracetamol multiple interactions ISO RGD:1353040 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5F1D mRNA CTD PMID:31059760 paracetamol decreases expression ISO RGD:1353040 6480464 Acetaminophen results in decreased expression of ATP5F1D mRNA CTD PMID:22230336 more ... perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:731351 6480464 PPARA protein inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of ATP5F1D mRNA] CTD PMID:20936131 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:731351 6480464 perfluorooctane sulfonic acid results in decreased expression of ATP5F1D mRNA CTD PMID:20936131 picrotoxin decreases expression EXP 6480464 Picrotoxin results in decreased expression of ATP5F1D mRNA CTD PMID:15170462 rotenone decreases expression ISO RGD:731351 6480464 Rotenone results in decreased expression of ATP5F1D mRNA CTD PMID:23186747 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ATP5F1D mRNA CTD PMID:19072884 sodium arsenite decreases expression ISO RGD:1353040 6480464 sodium arsenite results in decreased expression of ATP5F1D mRNA CTD PMID:34032870 sunitinib decreases expression ISO RGD:1353040 6480464 Sunitinib results in decreased expression of ATP5F1D mRNA CTD PMID:31533062 tetrachloroethene decreases expression ISO RGD:731351 6480464 Tetrachloroethylene results in decreased expression of ATP5F1D mRNA CTD PMID:28973375 thimerosal decreases expression ISO RGD:1353040 6480464 Thimerosal results in decreased expression of ATP5F1D mRNA CTD PMID:27188386 titanium dioxide increases expression ISO RGD:731351 6480464 titanium dioxide results in increased expression of ATP5F1D mRNA CTD PMID:23131501 triptonide decreases expression ISO RGD:731351 6480464 triptonide results in decreased expression of ATP5F1D mRNA CTD PMID:33045310 valproic acid increases methylation ISO RGD:1353040 6480464 Valproic Acid results in increased methylation of ATP5F1D gene CTD PMID:29154799 Y-27632 multiple interactions EXP 6480464 Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein] CTD PMID:25305180 zidovudine decreases expression ISO RGD:1353040 6480464 Zidovudine results in decreased expression of ATP5F1D mRNA CTD PMID:16894629